{"name":"Okairos","permalink":"okairos","crunchbase_url":"http://www.crunchbase.com/company/okairos","homepage_url":"http://www.okairos.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2007,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@okairos.com","phone_number":"+39 06 97246470","description":"bio-pharmaceutical company","created_at":"Wed Sep 15 18:45:47 UTC 2010","updated_at":"Wed Sep 15 18:53:50 UTC 2010","overview":"<p>Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. </p>\n\n<p>The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.</p>","image":{"available_sizes":[[[150,94],"assets/images/resized/0010/1873/101873v1-max-150x150.jpg"],[[222,140],"assets/images/resized/0010/1873/101873v1-max-250x250.jpg"],[[222,140],"assets/images/resized/0010/1873/101873v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$20.5M","funding_rounds":[{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/italys-okairos-raises-20-5m-vaccine-work/2010-09-14?utm_medium=rss&utm_source=rss","source_description":"Italy's Okairos raises $20.5M for vaccine work","raised_amount":20500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":14,"investments":[{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Boehringer Ingelheim Venture Fund","permalink":"boehringer-ingelheim-venture-fund","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"HQ","address1":"Elisabethenstrasse 3","address2":"","zip_code":"CH 4051","city":"Basel","state_code":null,"country_code":"CHE","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,104],"assets/images/resized/0010/1876/101876v1-max-150x150.jpg"],[[250,174],"assets/images/resized/0010/1876/101876v1-max-250x250.jpg"],[[450,313],"assets/images/resized/0010/1876/101876v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}